Thrombosis News and Research RSS Feed - Thrombosis News and Research

Thrombosis is the formation or presence of a thrombus (blood clot) inside a blood vessel.
ISTH joins with Wiley to introduce new open-access journal

ISTH joins with Wiley to introduce new open-access journal

The International Society on Thrombosis and Haemostasis (ISTH), in partnership with John Wiley and Sons, Inc., announces the launch of the Society's new open access journal, Research and Practice in Thrombosis and Haemostasis (RPTH), with its inaugural issue to publish in conjunction with the meeting of the ISTH 2017 Congress in Berlin, Germany, July 8-13. [More]
Thought leaders at U-CARS meeting to explore issues related to heart recovery and regeneration

Thought leaders at U-CARS meeting to explore issues related to heart recovery and regeneration

For many years, the answer to that question was unequivocally "No." But as the University of Utah School of Medicine's annual Utah Cardiac Recovery Symposium will explore on Jan. 12-13, advances in treating heart failure are giving physicians, surgeons and researchers reason to hope the deadly disease might one day be defeated. [More]
Study suggests using hypertonic saline infusions via peripheral catheter may help avoid complications

Study suggests using hypertonic saline infusions via peripheral catheter may help avoid complications

Current recommendations that a central catheter is required for continuous intravenous infusion of 3 percent sodium chloride solution should be re-evaluated, according to a study in the American Journal of Critical Care. [More]
CRCHUM receives NIH grant to study ways to prevent mortality after myocardial infarction

CRCHUM receives NIH grant to study ways to prevent mortality after myocardial infarction

The University of Montreal Hospital Research Centre has been awarded a grant of US$2 million from the National Institutes of Health to pilot the Canadian component of a study to determine the optimal amount of blood to transfuse in anemic patients who have suffered a myocardial infarction. [More]
Hormonal contraception least likely to be linked to thromboembolic events in diabetic women

Hormonal contraception least likely to be linked to thromboembolic events in diabetic women

Strokes and heart attacks are rare for women with diabetes who use hormonal contraception, with the safest options being intrauterine devices (IUDs) and under-the-skin implants, new research published in Diabetes Care shows. [More]
Studies show how overactive immune response may contribute to heart disease in psoriasis patients

Studies show how overactive immune response may contribute to heart disease in psoriasis patients

Psoriasis is well-known for causing too many skin cells on elbows, knees, and across the body, but people living with psoriasis may also be at an increased risk of heart disease. [More]
New self-regulating smart patch releases blood-thinning drugs when necessary

New self-regulating smart patch releases blood-thinning drugs when necessary

An interdisciplinary team of researchers has developed a smart patch designed to monitor a patient's blood and release blood-thinning drugs as needed to prevent the occurrence of dangerous blood clots - a condition known as thrombosis. [More]
New treatment strategy effective in preventing bleeding in AF patients who underwent PCI, study shows

New treatment strategy effective in preventing bleeding in AF patients who underwent PCI, study shows

A new study led by clinician-researchers at Beth Israel Deaconess Medical Center testing the safety and effectiveness of anticoagulant strategies for patients with atrial fibrillation who undergo stenting procedures has shown that therapies combining the anticoagulant drug rivaroxaban with either single or dual anti-platelet therapy were more effective in preventing bleeding complications than the current standard of care. [More]
Inhealthcare launches new mobile app to help NHS patients monitor, manage long-term conditions

Inhealthcare launches new mobile app to help NHS patients monitor, manage long-term conditions

Digital health specialist Inhealthcare has launched a new mobile app to help NHS patients track, monitor and manage long-term conditions including high blood pressure, diabetes and obesity. [More]
Study of new polymer-free DFS indicates non-inferior in-stent late lumen loss at nine-months

Study of new polymer-free DFS indicates non-inferior in-stent late lumen loss at nine-months

A first-in-human study of a new polymer-free drug-filled stent, which provides controlled drug elution from an internal lumen, indicated non-inferior in-stent late lumen loss at nine-months compared with historical zotarolimus-eluting stent (Resolute) data. In addition, there was no binary restenosis, and a high degree of early stent strut coverage with minimal malapposition. [More]
PLATINUM DIVERSITY study evaluates clinical outcomes after stent implantation in women, minorities

PLATINUM DIVERSITY study evaluates clinical outcomes after stent implantation in women, minorities

A dedicated stent study conducted exclusively in women and minority patients evaluated clinical outcomes within the era of contemporary PCI, comparing these results to a parallel cohort of white male patients. [More]
RESPECT study: PFO closure more beneficial than medical management in reducing recurrent stroke

RESPECT study: PFO closure more beneficial than medical management in reducing recurrent stroke

Final results from the RESPECT trial found that percutaneously closing a patent foramen ovale (PFO) using the Amplatzer PFO Occluder was superior to medical management in the prevention of recurrent ischemic stroke in patients who previously had a cryptogenic stroke. [More]
TCT 2016 features first report investigations on novel bioresorbable stents

TCT 2016 features first report investigations on novel bioresorbable stents

The 28th annual Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation featured a number of first report investigations on novel stents that could become the next generation of bioresorbable stents in patients. [More]
New method provides cost-effective way to effectively diagnose genetic forms of high-cholesterol

New method provides cost-effective way to effectively diagnose genetic forms of high-cholesterol

A new genetic testing method developed at Western University called LipidSeq can identify a genetic basis for high-cholesterol in almost 70 per cent of a targeted patient population. [More]
Study finds blood thinning drugs derived from cattle and pigs have equivalent anti-clotting properties

Study finds blood thinning drugs derived from cattle and pigs have equivalent anti-clotting properties

As demand for the widely used blood thinning drug heparin continues to grow, experts worry of possible shortages of the essential medication. [More]
Siemens announces FDA 510(k) clearance for Xprecia Stride Coagulation Analyzer

Siemens announces FDA 510(k) clearance for Xprecia Stride Coagulation Analyzer

Siemens Healthineers has more than 30 years of central lab hemostasis leadership. Building on to its portfolio, the company announced today FDA 510(k) clearance for a hand-held portable coagulation analyzer. [More]
Study finds potential for decrease in tobacco use by transgender women who receive hormone therapy

Study finds potential for decrease in tobacco use by transgender women who receive hormone therapy

While there has been much concern about the potential harm from transgender medical intervention (hormone therapy), a new study has found that transgender women who receive hormone therapy are more likely to quit or decrease smoking cigarettes as compared to the general population. [More]
Managing low-risk acute care without hospitalization appears to be safe and reduces costs

Managing low-risk acute care without hospitalization appears to be safe and reduces costs

A comprehensive review of studies evaluating strategies for treating certain acute medical conditions without hospital admission finds that all four evaluated strategies appear to be safe, often improve patient and caregiver satisfaction, and reduce health care costs. [More]
Cesarean-section leaves women more vulnerable to VTE than vaginal delivery

Cesarean-section leaves women more vulnerable to VTE than vaginal delivery

Roughly one-third of all births in Europe and North America now occur via cesarean section (CS). Following any birth, women are at an increased risk for a venous thromboembolism (VTE), but it's believed that CS leaves women more vulnerable to VTE, blood clots, than vaginal delivery (VD). [More]
Scientists use novel theranostics technique for early thromboembolism diagnosis and treatment

Scientists use novel theranostics technique for early thromboembolism diagnosis and treatment

Researchers from the University of Arkansas for Medical Science (USA), in collaboration with University Hospital Frankfurt and University Hospital Dresden, under the supervision of Prof. Vladimir Zharov and with the participation of Alexander Melerzanov, the dean of Department of Biological and Medical Physics (MIPT), conducted experiments on mice to detect blood clotting using photoacoustic flow-cytometry. [More]
Advertisement
Advertisement